Antibiotic-Resistant Infections: Why Doctors Are Turning to Zavicefta for Hard-to-Treat Cases
Serious bacterial infections can sometimes be difficult to treat, especially when the bacteria no longer respond to commonly used antibiotics.1 In these situations, doctors may consider other treatment options based on the type of infection, the bacteria causing it, and antibiotic susceptibility test results.
Why Antibiotic Resistance is a Problem?
Antibiotics are medicines used to treat bacterial infections. Antibiotic resistance occurs when bacteria change over time and no longer respond to antibiotics that once worked against them. As a result, infections become more difficult to treat and may increase the risk of disease spread, severe illness, and death.1
Antibiotic resistance has become a major global public health concern. The World Health Organization has identified antimicrobial resistance as one of the top 10 global public health threats. The problem continues to grow because bacteria naturally develop resistance over time, and the unnecessary or inappropriate use of antibiotics can speed up this process. As resistant bacteria become more common and fewer new antibiotics are available, treating serious infections becomes increasingly challenging.1
What are Gram-negative Bacterial Infections?
Gram-negative bacteria are a group of bacteria that has developed resistance to antibiotics. These organisms are especially important in hospitals, where they increase the risk of serious illness and death, particularly among patients in intensive care units.2
Because of their increasing resistance to available antibiotics, gram-negative infections are particularly challenging to manage and remain an important focus of global healthcare.2
Why Do Some Serious Infections Not Respond to Common Antibiotics?
Some serious infections do not respond to commonly used antibiotics because the bacteria causing them have developed resistance to one or more antibiotics. In some cases, bacteria become resistant to multiple antibiotics (multidrug resistance), making infections more difficult to treat.1
Factors that contribute to antibiotic resistance are as follows1:
- Unnecessary or inappropriate use of antibiotics
- Taking antibiotics when they are not needed, such as for viral infections
- Not using antibiotics as prescribed (for example, taking them for the wrong duration)
- Poor adherence to hygiene and infection-control measures, which can promote the spread of resistant bacteria
What Is Zavicefta?
Zavicefta is a combination of two active ingredients – ceftazidime and avibactam – that work together against certain bacteria. Ceftazidime attacks the bacterial cell wall, causing bacteria to break apart and die. Some bacteria produce enzymes called β-lactamases that can destroy β‑lactam antibiotics and reduce treatment effectiveness. This is where avibactam helps. Avibactam inhibits several important β-lactamase enzymes, protecting ceftazidime so it can remain active against organisms that would otherwise be difficult to treat.3,4
When May Your Doctors Consider Zavicefta?
Doctors may consider Zavicefta for treating certain serious bacterial infections in adults and children from birth3:
- Complicated intra-abdominal infections
- Complicated urinary tract infections (UTIs)
- Hospital-acquired pneumonia, including ventilator-associated pneumonia
In adults, Zavicefta may also be used for bacteraemia (bacteria in the bloodstream) when it occurs with, or is suspected to be associated with, these infections.3
Zavicefta for Serious Bacterial Infections
Zavicefta has been studied in adults with serious bacterial infections, including complicated intra-abdominal infections, complicated UTIs, and hospital-acquired pneumonia, including ventilator-associated pneumonia. In these studies, Zavicefta was shown to be effective in treating these serious bacterial infections when used in appropriate patients. For complicated intra-abdominal infections, Zavicefta is used in combination with metronidazole.3
Why Do Culture Tests and Antibiotic Sensitivity Reports Matter?
Zavicefta is used to treat serious infections caused by antibiotic-resistant gram-negative infections. Before starting treatment, doctors may perform culture and antibiotic susceptibility (sensitivity) testing to identify the bacteria causing the infection and determine whether Zavicefta is likely to be an appropriate treatment.3
How is Zavicefta Usually Given in Hospital Settings?
Zavicefta is given as an intravenous infusion in a hospital or other supervised healthcare setting. It is administered directly into a vein. In adults, each dose is typically given as a 2-hour IV infusion using an appropriate infusion volume. In children, the doctor may adjust the infusion volume and dosing as needed.3
What Safety Checks Are Done During Zavicefta Treatment?
Before and during treatment with Zavicefta, your doctor may monitor you to help ensure the medicine is used safely and effectively. This may include the following3:
- Checking your kidney function, as Zavicefta is removed from the body through the kidneys and the dose may need to be adjusted if kidney function is reduced
- Asking about any allergies, especially to ceftazidime, other cephalosporins, or β‑lactam antibiotics before starting treatment
- Monitoring for allergic reactions or other serious side effects during treatment
- Enquiring about persistent or severe diarrhoea, since this may require further assessment
- Investigating signs of anaemia during or after treatment.
Regular monitoring helps your doctor assess both the effectiveness and safety of treatment throughout the course of therapy.3
How Rx4U May Help with Access Support Through Named Patient Program Guidance?
Rx4U states that it helps patients and doctors access medicines through a Named Patient Program (NPP). The process includes registration, order verification, quotation preparation, payment, connection with the source, and medicine delivery.5
Rx4U also states that it supports import- and customs-related processes. Patients may be required to provide a signed and stamped prescription from their doctor, relevant medical records, and identification documents. Rx4U mentions that medicines are sourced directly from manufacturers or authorized distributors and supplied through the NPP.5
Conclusion: Treating Resistant Infections Requires Specialist-Led Care
Antibiotic-resistant infections can be difficult to treat, and choosing the right antibiotic is crucial. For some serious infections, your doctors may consider Zavicefta. Your doctor will determine the most appropriate treatment based on the type of infection, culture results, kidney function, and your individual condition and monitor your response throughout treatment.1-3
Frequently Asked Questions
- What is Zavicefta used for?
Zavicefta is used for certain serious bacterial infections, including complicated intra-abdominal infections, complicated UTIs, and hospital-acquired pneumonia, including ventilator-associated pneumonia.3
- Is Zavicefta used for antibiotic-resistant infections?
Zavicefta may be considered for infections caused by certain difficult-to-treat gram-negative bacteria.3
- Why do doctors check culture reports before using Zavicefta?
Culture and sensitivity tests help identify whether the bacteria causing the infection are likely to respond to treatment.3
- Is Zavicefta given at home or in a hospital?
Zavicefta is given as an intravenous infusion in a hospital setting.3
- How can patients access Zavicefta with support?
Patients may receive guidance through NPP support services such as Rx4U.5
Medical Disclaimer
This information is provided for educational purposes only and is not a substitute for professional medical advice. Zavicefta (ceftazidime and avibactam) should only be taken under the guidance of a qualified healthcare provider. Patients should always consult their doctor or pharmacist for advice on diagnosis, treatment, and medication use, and should not make changes to their prescribed therapy without medical supervision.
References
- Nwobodo DC, Ugwu MC, Anie CO, et al. Antibiotic resistance: the challenges and some emerging strategies for tackling a global menace. J Clin Lab Anal. 2022;36(9):e24655. doi:10.1002/jcla.24655
- Oliveira J, Reygaert WC. Gram-negative bacteria. In: StatPearls. StatPearls Publishing; 2023. Updated August 8, 2023. https://www.ncbi.nlm.nih.gov/books/NBK538213/
- Zavicefta (ceftazidime and avibactam). Prescribing information. Pfizer Inc. 2026. Accessed July 17, 2026. https://labeling.pfizer.com/ShowLabeling.aspx?id=13526
- Zavicefta: EPAR – medicine overview. European Medicines Agency. Accessed July 17, 2026. https://www.ema.europa.eu/en/documents/overview/zavicefta-epar-medicine-overview_en.pdf
- Named Patient Program. Rx4u. Accessed July 17, 2026. https://rx4u.in
Note:
The information provided is for education purpose only and is subjected to prescribing information of the drug and the guidance of your treating physician. Always consult your health care provider before making any medical decision for starting your treatment.
Disclaimer:
Rx4U procures prescribed medicines directly from manufacturers or authorized distributors. It does not claim ownership of any trademarks and complies with the provisions of the Trademark Act, 1999, particularly Sections 30 and 30(1) concerning ‘Fair Use’. It solely facilitates access to new launches through named patient import.
